Uncategorized Streebo Spin’s Off Life Science Business as qordata Thomas Sullivan Apr 4, 2016 0 Spinoff's, Mergers and Acquisitions abound in the life science compliance firm. One firm Streebo the creators of Open…
Prescription Drug Prices Specialty Pricing Drugs: How Did We Get Here and Where Do We Go Thomas Sullivan Apr 1, 2016 0 The American Enterprise Institute recently published a research publication on specialty drug pricing. The publication,…
State Policy Massachusetts Medical Society Requires Social Media Disclosure by… Thomas Sullivan Apr 1, 2016 0 The idea that doctors are promoting treatments on social media has gotten some attention from media outlets over the…
Congress MACRA Progress Report: Subcommittee on Health Hearing Thomas Sullivan Mar 31, 2016 0 According to Politico the draft rule for the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA) has been…
HHS New HIPAA Audits Announced Thomas Sullivan Mar 30, 2016 0 After many years of anticipation, the Office of Civil Rights (OCR) launched a new round of audits to gauge compliance…
FDA FDA Announces Labeling Changes for Immediate Release Opioid Medications Thomas Sullivan Mar 29, 2016 0 The United States Food and Drug Administration has announced new required class-wide safety labeling changes for…
Medical Legal More Legal Trouble Ahead for Horizon Pharma Thomas Sullivan Mar 29, 2016 0 Horizon Pharma has been in the spotlight for questionable ties to specialty pharmacies and its patient assistance…
Corporate Integrity Agreements Respironics Settlement and Corporate Integrity Agreement Thomas Sullivan Mar 28, 2016 0 One more False Claims Act case has been settled; this time Respironics, Inc., who allegedly violated the False Claims…
Congress House Oversight Committee: America’s Heroin and Opioid Abuse Epidemic Thomas Sullivan Mar 25, 2016 0 On the same day that the FDA issued black box warning to all immediate release opioids, the House Committee on Oversight…
FCPA Novartis Settles China Foreign Corrupt Practices Complaint Thomas Sullivan Mar 24, 2016 0 Novartis AG has settled civil charges against the company, for $25 million to the United States Securities and Exchange…